Case Series
Concurrence of Rheumatoid Arthritis and Ankylosing Spondylitis: Analysis of Seven Cases and Literature Review
Table 3
Radiological, laboratory, and treatment characteristics.
| | n = 81 (percentage) |
| Syndesmophytes (radiograph/MR/CT) | 42/57 (73.68%) | Radiographic erosions | 65/76 (85.52%) | Radiological sacroiliitis | 80/81 (98.76%) | Positive RF | 73/79 (92.40%) | Citrullinated peptide antibodies | 16/18 (88.88%) | Positive HLA B-27 | 60/67 (89.55%) | Treatment | | NSAIDs | 28/47 (59.57%) | Corticosteroids | 39/47 (82.97%) | Gold salts | 12/47 (25.53%) | Hydroxychloroquine | 9/47 (19.14%) | Sulfasalazine | 9/47 (19.14%) | Methotrexate | 15/47 (31.91%) | Leflunomide | 4/47 (8.51%) | TNF-α-i | 5/47 (10.63%) | Others | 6/47 (12.76%) |
|
|
CT: computerized tomography; MR: magnetic resonance, NSAIDs: nonsteroidal anti-inflammatory drugs; RF: rheumatoid factor; TNF-i: tumor necrosis factor inhibitor.
|